English | Español
English | Español
  • Insurance
  • Marketing
  • Pharmaceuticals
  • Technology/Innovation
  • Regulatory
  • Community

Technology/Innovation

+ Technology/Innovation
Jamie Barrand | Dec 2, 2015

Lawmakers introduce 'REPEAL' HIV Discrimination Act

+ Technology/Innovation
Jamie Barrand | Dec 2, 2015

African Americans with depression more likely to suffer strokes, coronary disease, AHA study shows

+ Technology/Innovation
Jamie Barrand | Dec 1, 2015

Synthetic Biologics releases study results for SYN-004

+ Technology/Innovation
Jamie Barrand | Dec 1, 2015

Study looks at link between pollution, heart disease in diabetic women

+ Technology/Innovation
Jamie Barrand | Dec 1, 2015

Empliciti approved by FDA for treatment of multiple myeloma

+ Technology/Innovation
Kerry Goff | Dec 1, 2015

University of Toronto's new ALS research may have pinpointed cause of disease

+ Technology/Innovation
Jamie Barrand | Nov 26, 2015

Intravenous form of ibuprofen now available in Australia

+ Technology/Innovation
Jamie Barrand | Nov 25, 2015

CRS-207 designated as orphan drug for mesothelioma treatment

Trending

+ Pharmaceuticals
Patient Daily | Aug 4, 2026

Merck reports mixed results for tulisokibart in recent clinical trials and financial update

+ Pharmaceuticals
Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate

+ Regulatory
M. R. Armstrong | Aug 4, 2026

Public Policy Solutions on 340B: 'The program has enriched big hospital execs'

+ Pharmaceuticals
Patient Daily | Aug 5, 2026

Bristol Myers Squibb and AstraZeneca reportedly in merger talks amid industry changes

  • « First
  • «
  • …
  • 69
  • 70
  • 71
  • 72
  • 73
  • 74
  • 75
  • »
  • Last »


Community
Insurance
Marketing
Pharmaceuticals
Regulatory
Technology/Innovation
About
Contact
© 2026 Patient Daily